Literature DB >> 7866407

FH-Sydney 1 and 2: two novel frameshift mutations in exon 10 of the low-density lipoprotein receptor gene detected by heteroduplex formation.

J A Cavanaugh1, S Easteal, L A Simons, D W Thomas, S W Serjeantson.   

Abstract

We report two novel frameshift mutations in exon 10 of the low-density lipoprotein receptor gene that lead to familial hypercholesterolemia in separate lineages. The lesions, FH-Sydney 1 and FH-Sydney 2, were detected by a modified heteroduplex analysis of exon-specific polymerase chain reaction (PCR) amplified DNA, and characterized at the molecular level by sequencing. Restriction enzyme digestion of PCR amplified DNA confirmed the presence of the mutant alleles in affected family members and their absence in nonaffected family members in both lineages. FH-Sydney 1 is a 4-bp duplication at position 1373, while FH-Sydney 2 is a 2-bp deletion at position 1478. The predicted result of both mutations is the premature truncation of the receptor at stop codons generated downstream of the mutations. Neither mutation was detected in a survey of 54 unrelated familial hypercholesterolemia patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7866407     DOI: 10.1002/humu.1380040408

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  2 in total

1.  Software and database for the analysis of mutations in the human LDL receptor gene.

Authors:  M Varret; J P Rabès; G Collod-Béroud; C Junien; C Boileau; C Béroud
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

2.  An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations.

Authors:  Maria Romano; Maria Donata Di Taranto; Peppino Mirabelli; Maria Nicoletta D'Agostino; Arcangelo Iannuzzi; Gennaro Marotta; Marco Gentile; Maddalena Raia; Rosa Di Noto; Luigi Del Vecchio; Paolo Rubba; Giuliana Fortunato
Journal:  J Lipid Res       Date:  2011-08-24       Impact factor: 5.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.